 | • レポートコード：QFJ1-5051 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、ゾルピプラムの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（舌下錠、経口スプレー）、用途別市場規模（散発性不眠症、一過性不眠症）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・ゾルピプラムの市場動向 ・企業の競争状況、市場シェア ・ゾルピプラムの種類別市場規模と予測2016-2027（舌下錠、経口スプレー） ・ゾルピプラムの用途別市場規模と予測2016-2027（散発性不眠症、一過性不眠症） ・ゾルピプラムの北米市場規模2016-2027（アメリカ、カナダ） ・ゾルピプラムの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・ゾルピプラムのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ゾルピプラムの中南米市場規模2016-2027（メキシコ、ブラジル） ・ゾルピプラムの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Sanofi、Hikma Pharmaceuticals、Northstar Rx、Teva Pharmaceuticals、Torrent Pharma、Apotex、Endo、Mylan Pharmaceuticals、Synthelabo Groupe、Hu'nan Qianjin Xiangjiang Pharmaceutical、Jiangsu Haosen Pharmaceutical Group、Shanxi Quantum hi-tech Pharmaceutical、Shanghai Shyndec Pharmaceutical、Lunan Pharmaceutical） ・結論 |
Zolpipram generally refers to sinosi (zolpipram tartrate tablets), indications for this product is limited for the treatment of occasional insomnia, temporary insomnia serious sleep disorders.
Market Analysis and Insights: Global Zolpipram Market
The global Zolpipram market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Zolpipram market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Zolpipram market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Zolpipram market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Zolpipram market.
Global Zolpipram Scope and Market Size
Zolpipram market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Zolpipram market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Sublingual Tablets
Oral Spray
Segment by Application
Sporadic Insomnia
Temporary Insomnia
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Sanofi
Hikma Pharmaceuticals
Northstar Rx
Teva Pharmaceuticals
Torrent Pharma
Apotex
Endo
Mylan Pharmaceuticals
Synthelabo Groupe
Hu’nan Qianjin Xiangjiang Pharmaceutical
Jiangsu Haosen Pharmaceutical Group
Shanxi Quantum hi-tech Pharmaceutical
Shanghai Shyndec Pharmaceutical
Lunan Pharmaceutical
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Zolpipram Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Sublingual Tablets
1.2.3 Oral Spray
1.3 Market by Application
1.3.1 Global Zolpipram Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Sporadic Insomnia
1.3.3 Temporary Insomnia
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Zolpipram Market Perspective (2016-2027)
2.2 Zolpipram Growth Trends by Regions
2.2.1 Zolpipram Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Zolpipram Historic Market Share by Regions (2016-2021)
2.2.3 Zolpipram Forecasted Market Size by Regions (2022-2027)
2.3 Zolpipram Industry Dynamic
2.3.1 Zolpipram Market Trends
2.3.2 Zolpipram Market Drivers
2.3.3 Zolpipram Market Challenges
2.3.4 Zolpipram Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Zolpipram Players by Revenue
3.1.1 Global Top Zolpipram Players by Revenue (2016-2021)
3.1.2 Global Zolpipram Revenue Market Share by Players (2016-2021)
3.2 Global Zolpipram Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Zolpipram Revenue
3.4 Global Zolpipram Market Concentration Ratio
3.4.1 Global Zolpipram Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Zolpipram Revenue in 2020
3.5 Zolpipram Key Players Head office and Area Served
3.6 Key Players Zolpipram Product Solution and Service
3.7 Date of Enter into Zolpipram Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Zolpipram Breakdown Data by Type
4.1 Global Zolpipram Historic Market Size by Type (2016-2021)
4.2 Global Zolpipram Forecasted Market Size by Type (2022-2027)
5 Zolpipram Breakdown Data by Application
5.1 Global Zolpipram Historic Market Size by Application (2016-2021)
5.2 Global Zolpipram Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Zolpipram Market Size (2016-2027)
6.2 North America Zolpipram Market Size by Type
6.2.1 North America Zolpipram Market Size by Type (2016-2021)
6.2.2 North America Zolpipram Market Size by Type (2022-2027)
6.2.3 North America Zolpipram Market Size by Type (2016-2027)
6.3 North America Zolpipram Market Size by Application
6.3.1 North America Zolpipram Market Size by Application (2016-2021)
6.3.2 North America Zolpipram Market Size by Application (2022-2027)
6.3.3 North America Zolpipram Market Size by Application (2016-2027)
6.4 North America Zolpipram Market Size by Country
6.4.1 North America Zolpipram Market Size by Country (2016-2021)
6.4.2 North America Zolpipram Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Zolpipram Market Size (2016-2027)
7.2 Europe Zolpipram Market Size by Type
7.2.1 Europe Zolpipram Market Size by Type (2016-2021)
7.2.2 Europe Zolpipram Market Size by Type (2022-2027)
7.2.3 Europe Zolpipram Market Size by Type (2016-2027)
7.3 Europe Zolpipram Market Size by Application
7.3.1 Europe Zolpipram Market Size by Application (2016-2021)
7.3.2 Europe Zolpipram Market Size by Application (2022-2027)
7.3.3 Europe Zolpipram Market Size by Application (2016-2027)
7.4 Europe Zolpipram Market Size by Country
7.4.1 Europe Zolpipram Market Size by Country (2016-2021)
7.4.2 Europe Zolpipram Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Zolpipram Market Size (2016-2027)
8.2 Asia-Pacific Zolpipram Market Size by Type
8.2.1 Asia-Pacific Zolpipram Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Zolpipram Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Zolpipram Market Size by Type (2016-2027)
8.3 Asia-Pacific Zolpipram Market Size by Application
8.3.1 Asia-Pacific Zolpipram Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Zolpipram Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Zolpipram Market Size by Application (2016-2027)
8.4 Asia-Pacific Zolpipram Market Size by Region
8.4.1 Asia-Pacific Zolpipram Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Zolpipram Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Zolpipram Market Size (2016-2027)
9.2 Latin America Zolpipram Market Size by Type
9.2.1 Latin America Zolpipram Market Size by Type (2016-2021)
9.2.2 Latin America Zolpipram Market Size by Type (2022-2027)
9.2.3 Latin America Zolpipram Market Size by Type (2016-2027)
9.3 Latin America Zolpipram Market Size by Application
9.3.1 Latin America Zolpipram Market Size by Application (2016-2021)
9.3.2 Latin America Zolpipram Market Size by Application (2022-2027)
9.3.3 Latin America Zolpipram Market Size by Application (2016-2027)
9.4 Latin America Zolpipram Market Size by Country
9.4.1 Latin America Zolpipram Market Size by Country (2016-2021)
9.4.2 Latin America Zolpipram Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Zolpipram Market Size (2016-2027)
10.2 Middle East & Africa Zolpipram Market Size by Type
10.2.1 Middle East & Africa Zolpipram Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Zolpipram Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Zolpipram Market Size by Type (2016-2027)
10.3 Middle East & Africa Zolpipram Market Size by Application
10.3.1 Middle East & Africa Zolpipram Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Zolpipram Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Zolpipram Market Size by Application (2016-2027)
10.4 Middle East & Africa Zolpipram Market Size by Country
10.4.1 Middle East & Africa Zolpipram Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Zolpipram Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Zolpipram Introduction
11.1.4 Sanofi Revenue in Zolpipram Business (2016-2021)
11.1.5 Sanofi Recent Development
11.2 Hikma Pharmaceuticals
11.2.1 Hikma Pharmaceuticals Company Details
11.2.2 Hikma Pharmaceuticals Business Overview
11.2.3 Hikma Pharmaceuticals Zolpipram Introduction
11.2.4 Hikma Pharmaceuticals Revenue in Zolpipram Business (2016-2021)
11.2.5 Hikma Pharmaceuticals Recent Development
11.3 Northstar Rx
11.3.1 Northstar Rx Company Details
11.3.2 Northstar Rx Business Overview
11.3.3 Northstar Rx Zolpipram Introduction
11.3.4 Northstar Rx Revenue in Zolpipram Business (2016-2021)
11.3.5 Northstar Rx Recent Development
11.4 Teva Pharmaceuticals
11.4.1 Teva Pharmaceuticals Company Details
11.4.2 Teva Pharmaceuticals Business Overview
11.4.3 Teva Pharmaceuticals Zolpipram Introduction
11.4.4 Teva Pharmaceuticals Revenue in Zolpipram Business (2016-2021)
11.4.5 Teva Pharmaceuticals Recent Development
11.5 Torrent Pharma
11.5.1 Torrent Pharma Company Details
11.5.2 Torrent Pharma Business Overview
11.5.3 Torrent Pharma Zolpipram Introduction
11.5.4 Torrent Pharma Revenue in Zolpipram Business (2016-2021)
11.5.5 Torrent Pharma Recent Development
11.6 Apotex
11.6.1 Apotex Company Details
11.6.2 Apotex Business Overview
11.6.3 Apotex Zolpipram Introduction
11.6.4 Apotex Revenue in Zolpipram Business (2016-2021)
11.6.5 Apotex Recent Development
11.7 Endo
11.7.1 Endo Company Details
11.7.2 Endo Business Overview
11.7.3 Endo Zolpipram Introduction
11.7.4 Endo Revenue in Zolpipram Business (2016-2021)
11.7.5 Endo Recent Development
11.8 Mylan Pharmaceuticals
11.8.1 Mylan Pharmaceuticals Company Details
11.8.2 Mylan Pharmaceuticals Business Overview
11.8.3 Mylan Pharmaceuticals Zolpipram Introduction
11.8.4 Mylan Pharmaceuticals Revenue in Zolpipram Business (2016-2021)
11.8.5 Mylan Pharmaceuticals Recent Development
11.9 Synthelabo Groupe
11.9.1 Synthelabo Groupe Company Details
11.9.2 Synthelabo Groupe Business Overview
11.9.3 Synthelabo Groupe Zolpipram Introduction
11.9.4 Synthelabo Groupe Revenue in Zolpipram Business (2016-2021)
11.9.5 Synthelabo Groupe Recent Development
11.10 Hu’nan Qianjin Xiangjiang Pharmaceutical
11.10.1 Hu’nan Qianjin Xiangjiang Pharmaceutical Company Details
11.10.2 Hu’nan Qianjin Xiangjiang Pharmaceutical Business Overview
11.10.3 Hu’nan Qianjin Xiangjiang Pharmaceutical Zolpipram Introduction
11.10.4 Hu’nan Qianjin Xiangjiang Pharmaceutical Revenue in Zolpipram Business (2016-2021)
11.10.5 Hu’nan Qianjin Xiangjiang Pharmaceutical Recent Development
11.11 Jiangsu Haosen Pharmaceutical Group
11.11.1 Jiangsu Haosen Pharmaceutical Group Company Details
11.11.2 Jiangsu Haosen Pharmaceutical Group Business Overview
11.11.3 Jiangsu Haosen Pharmaceutical Group Zolpipram Introduction
11.11.4 Jiangsu Haosen Pharmaceutical Group Revenue in Zolpipram Business (2016-2021)
11.11.5 Jiangsu Haosen Pharmaceutical Group Recent Development
11.12 Shanxi Quantum hi-tech Pharmaceutical
11.12.1 Shanxi Quantum hi-tech Pharmaceutical Company Details
11.12.2 Shanxi Quantum hi-tech Pharmaceutical Business Overview
11.12.3 Shanxi Quantum hi-tech Pharmaceutical Zolpipram Introduction
11.12.4 Shanxi Quantum hi-tech Pharmaceutical Revenue in Zolpipram Business (2016-2021)
11.12.5 Shanxi Quantum hi-tech Pharmaceutical Recent Development
11.13 Shanghai Shyndec Pharmaceutical
11.13.1 Shanghai Shyndec Pharmaceutical Company Details
11.13.2 Shanghai Shyndec Pharmaceutical Business Overview
11.13.3 Shanghai Shyndec Pharmaceutical Zolpipram Introduction
11.13.4 Shanghai Shyndec Pharmaceutical Revenue in Zolpipram Business (2016-2021)
11.13.5 Shanghai Shyndec Pharmaceutical Recent Development
11.14 Lunan Pharmaceutical
11.14.1 Lunan Pharmaceutical Company Details
11.14.2 Lunan Pharmaceutical Business Overview
11.14.3 Lunan Pharmaceutical Zolpipram Introduction
11.14.4 Lunan Pharmaceutical Revenue in Zolpipram Business (2016-2021)
11.14.5 Lunan Pharmaceutical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Zolpipram Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Sublingual Tablets
Table 3. Key Players of Oral Spray
Table 4. Global Zolpipram Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Zolpipram Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Zolpipram Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Zolpipram Market Share by Regions (2016-2021)
Table 8. Global Zolpipram Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Zolpipram Market Share by Regions (2022-2027)
Table 10. Zolpipram Market Trends
Table 11. Zolpipram Market Drivers
Table 12. Zolpipram Market Challenges
Table 13. Zolpipram Market Restraints
Table 14. Global Zolpipram Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Zolpipram Market Share by Players (2016-2021)
Table 16. Global Top Zolpipram Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Zolpipram as of 2020)
Table 17. Ranking of Global Top Zolpipram Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Zolpipram Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Zolpipram Product Solution and Service
Table 21. Date of Enter into Zolpipram Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Zolpipram Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Zolpipram Revenue Market Share by Type (2016-2021)
Table 25. Global Zolpipram Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Zolpipram Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Zolpipram Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Zolpipram Revenue Market Share by Application (2016-2021)
Table 29. Global Zolpipram Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Zolpipram Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Zolpipram Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Zolpipram Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Zolpipram Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Zolpipram Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Zolpipram Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Zolpipram Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Zolpipram Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Zolpipram Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Zolpipram Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Zolpipram Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Zolpipram Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Zolpipram Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Zolpipram Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Zolpipram Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Zolpipram Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Zolpipram Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Zolpipram Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Zolpipram Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Zolpipram Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Zolpipram Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Zolpipram Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Zolpipram Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Zolpipram Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Zolpipram Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Zolpipram Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Zolpipram Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Zolpipram Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Zolpipram Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Zolpipram Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Zolpipram Market Size by Country (2022-2027) & (US$ Million)
Table 61. Sanofi Company Details
Table 62. Sanofi Business Overview
Table 63. Sanofi Zolpipram Product
Table 64. Sanofi Revenue in Zolpipram Business (2016-2021) & (US$ Million)
Table 65. Sanofi Recent Development
Table 66. Hikma Pharmaceuticals Company Details
Table 67. Hikma Pharmaceuticals Business Overview
Table 68. Hikma Pharmaceuticals Zolpipram Product
Table 69. Hikma Pharmaceuticals Revenue in Zolpipram Business (2016-2021) & (US$ Million)
Table 70. Hikma Pharmaceuticals Recent Development
Table 71. Northstar Rx Company Details
Table 72. Northstar Rx Business Overview
Table 73. Northstar Rx Zolpipram Product
Table 74. Northstar Rx Revenue in Zolpipram Business (2016-2021) & (US$ Million)
Table 75. Northstar Rx Recent Development
Table 76. Teva Pharmaceuticals Company Details
Table 77. Teva Pharmaceuticals Business Overview
Table 78. Teva Pharmaceuticals Zolpipram Product
Table 79. Teva Pharmaceuticals Revenue in Zolpipram Business (2016-2021) & (US$ Million)
Table 80. Teva Pharmaceuticals Recent Development
Table 81. Torrent Pharma Company Details
Table 82. Torrent Pharma Business Overview
Table 83. Torrent Pharma Zolpipram Product
Table 84. Torrent Pharma Revenue in Zolpipram Business (2016-2021) & (US$ Million)
Table 85. Torrent Pharma Recent Development
Table 86. Apotex Company Details
Table 87. Apotex Business Overview
Table 88. Apotex Zolpipram Product
Table 89. Apotex Revenue in Zolpipram Business (2016-2021) & (US$ Million)
Table 90. Apotex Recent Development
Table 91. Endo Company Details
Table 92. Endo Business Overview
Table 93. Endo Zolpipram Product
Table 94. Endo Revenue in Zolpipram Business (2016-2021) & (US$ Million)
Table 95. Endo Recent Development
Table 96. Mylan Pharmaceuticals Company Details
Table 97. Mylan Pharmaceuticals Business Overview
Table 98. Mylan Pharmaceuticals Revenue in Zolpipram Business (2016-2021) & (US$ Million)
Table 99. Mylan Pharmaceuticals Recent Development
Table 100. Synthelabo Groupe Company Details
Table 101. Synthelabo Groupe Business Overview
Table 102. Synthelabo Groupe Zolpipram Product
Table 103. Synthelabo Groupe Revenue in Zolpipram Business (2016-2021) & (US$ Million)
Table 104. Synthelabo Groupe Recent Development
Table 105. Hu'nan Qianjin Xiangjiang Pharmaceutical Company Details
Table 106. Hu'nan Qianjin Xiangjiang Pharmaceutical Business Overview
Table 107. Hu'nan Qianjin Xiangjiang Pharmaceutical Zolpipram Product
Table 108. Hu'nan Qianjin Xiangjiang Pharmaceutical Revenue in Zolpipram Business (2016-2021) & (US$ Million)
Table 109. Hu'nan Qianjin Xiangjiang Pharmaceutical Recent Development
Table 110. Jiangsu Haosen Pharmaceutical Group Company Details
Table 111. Jiangsu Haosen Pharmaceutical Group Business Overview
Table 112. Jiangsu Haosen Pharmaceutical Group Zolpipram Product
Table 113. Jiangsu Haosen Pharmaceutical Group Revenue in Zolpipram Business (2016-2021) & (US$ Million)
Table 114. Jiangsu Haosen Pharmaceutical Group Recent Development
Table 115. Shanxi Quantum hi-tech Pharmaceutical Company Details
Table 116. Shanxi Quantum hi-tech Pharmaceutical Business Overview
Table 117. Shanxi Quantum hi-tech Pharmaceutical Zolpipram Product
Table 118. Shanxi Quantum hi-tech Pharmaceutical Revenue in Zolpipram Business (2016-2021) & (US$ Million)
Table 119. Shanxi Quantum hi-tech Pharmaceutical Recent Development
Table 120. Shanghai Shyndec Pharmaceutical Company Details
Table 121. Shanghai Shyndec Pharmaceutical Business Overview
Table 122. Shanghai Shyndec Pharmaceutical Zolpipram Product
Table 123. Shanghai Shyndec Pharmaceutical Revenue in Zolpipram Business (2016-2021) & (US$ Million)
Table 124. Shanghai Shyndec Pharmaceutical Recent Development
Table 125. Lunan Pharmaceutical Company Details
Table 126. Lunan Pharmaceutical Business Overview
Table 127. Lunan Pharmaceutical Zolpipram Product
Table 128. Lunan Pharmaceutical Revenue in Zolpipram Business (2016-2021) & (US$ Million)
Table 129. Lunan Pharmaceutical Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Zolpipram Market Share by Type: 2020 VS 2027
Figure 2. Sublingual Tablets Features
Figure 3. Oral Spray Features
Figure 4. Global Zolpipram Market Share by Application: 2020 VS 2027
Figure 5. Sporadic Insomnia Case Studies
Figure 6. Temporary Insomnia Case Studies
Figure 7. Zolpipram Report Years Considered
Figure 8. Global Zolpipram Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Zolpipram Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Zolpipram Market Share by Regions: 2020 VS 2027
Figure 11. Global Zolpipram Market Share by Regions (2022-2027)
Figure 12. Global Zolpipram Market Share by Players in 2020
Figure 13. Global Top Zolpipram Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Zolpipram as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Zolpipram Revenue in 2020
Figure 15. Global Zolpipram Revenue Market Share by Type (2016-2021)
Figure 16. Global Zolpipram Revenue Market Share by Type (2022-2027)
Figure 17. North America Zolpipram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Zolpipram Market Share by Type (2016-2027)
Figure 19. North America Zolpipram Market Share by Application (2016-2027)
Figure 20. North America Zolpipram Market Share by Country (2016-2027)
Figure 21. United States Zolpipram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Zolpipram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Zolpipram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Zolpipram Market Share by Type (2016-2027)
Figure 25. Europe Zolpipram Market Share by Application (2016-2027)
Figure 26. Europe Zolpipram Market Share by Country (2016-2027)
Figure 27. Germany Zolpipram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Zolpipram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Zolpipram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Zolpipram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Zolpipram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Zolpipram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Zolpipram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Zolpipram Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Zolpipram Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Zolpipram Market Share by Region (2016-2027)
Figure 37. China Zolpipram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Zolpipram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Zolpipram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Zolpipram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Zolpipram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Zolpipram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Zolpipram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Zolpipram Market Share by Type (2016-2027)
Figure 45. Latin America Zolpipram Market Share by Application (2016-2027)
Figure 46. Latin America Zolpipram Market Share by Country (2016-2027)
Figure 47. Mexico Zolpipram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Zolpipram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Zolpipram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Zolpipram Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Zolpipram Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Zolpipram Market Share by Country (2016-2027)
Figure 53. Turkey Zolpipram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Zolpipram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Zolpipram Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Sanofi Revenue Growth Rate in Zolpipram Business (2016-2021)
Figure 57. Hikma Pharmaceuticals Revenue Growth Rate in Zolpipram Business (2016-2021)
Figure 58. Northstar Rx Revenue Growth Rate in Zolpipram Business (2016-2021)
Figure 59. Teva Pharmaceuticals Revenue Growth Rate in Zolpipram Business (2016-2021)
Figure 60. Torrent Pharma Revenue Growth Rate in Zolpipram Business (2016-2021)
Figure 61. Apotex Revenue Growth Rate in Zolpipram Business (2016-2021)
Figure 62. Endo Revenue Growth Rate in Zolpipram Business (2016-2021)
Figure 63. Mylan Pharmaceuticals Revenue Growth Rate in Zolpipram Business (2016-2021)
Figure 64. Synthelabo Groupe Revenue Growth Rate in Zolpipram Business (2016-2021)
Figure 65. Hu'nan Qianjin Xiangjiang Pharmaceutical Revenue Growth Rate in Zolpipram Business (2016-2021)
Figure 66. Jiangsu Haosen Pharmaceutical Group Revenue Growth Rate in Zolpipram Business (2016-2021)
Figure 67. Shanxi Quantum hi-tech Pharmaceutical Revenue Growth Rate in Zolpipram Business (2016-2021)
Figure 68. Shanghai Shyndec Pharmaceutical Revenue Growth Rate in Zolpipram Business (2016-2021)
Figure 69. Lunan Pharmaceutical Revenue Growth Rate in Zolpipram Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界の不眠症治療薬市場規模・現状・予測（2021年-2027年） Insomnia is a sleep disorder characterized by difficulty falling and/or staying asleep. Insomnia medications can improve this condition. Market Analysis and Insights: Global Insomnia Treatment Drugs Market The global Insomnia Treatment Drugs market size is projected to reach US$ XX million by 2027, …- 世界の舌下アレルギー免疫療法市場規模・現状・予測（2021年-2027年） Sublingual Allergy Immunotherapy is a method of treating allergies by giving a drug under the tongue. Market Analysis and Insights: Global Sublingual Allergy Immunotherapy Market The global Sublingual Allergy Immunotherapy market size is projected to reach US$ XX million by 2027, from US$ XX million…
- 不眠症治療薬のグローバル市場：規模・現状・予測2019-2025 Insomnia is a sleep disorder characterized by difficulty falling and/or staying asleep. Insomnia medications can improve this condition.In 2018, the global Insomnia Treatment Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during…
- 不眠症治療薬のグローバル市場：規模・現状・予測2019-2025 Insomnia is a sleep disorder characterized by difficulty falling and/or staying asleep. Insomnia medications can improve this condition.In 2018, the global Insomnia Treatment Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during…
- 不眠症治療薬のグローバル市場：規模・現状・予測2019-2025 Insomnia is a sleep disorder characterized by difficulty falling and/or staying asleep. Insomnia medications can improve this condition.In 2018, the global Insomnia Treatment Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during…